Generated Narrative: MedicinalProductDefinition 600000709068 version: 3 Authorised Dose Form: Pharmaceutical Dose Form 100000073683: Prolonged-release tablet identifier: http://spor.azure-api.net/pms/api/v2/6055417 domain: Human use status: Nullified combinedPharmaceuticalDoseForm: 100000073683 indication: legalStatusOfSupply: Medicinal product not subject to medical prescription additionalMonitoringIndicator: False pediatricUseIndicator: True classification: 100000098024, Full application (Article 8(3) of Directive No 2001/83/EC), Other attachedDocument: DocumentReference: status = current masterFile: DocumentReference: status = current contact type: Pharmacovigilance Enquiry Information contact: Organization Dummmy Organization contact type: Qualified Person in the EEA for Pharmacovigilance contact: PractitionerRole name productName: StopCold 5 mg/120 mg comprimidos de liberación prolongada. part part: StopCold type: Invented name part part part: 5 MG/120 MG type: Strength part part part: COMPRIMIDOS DE LIBERACIÓN PROLONGADA type: Pharmaceutical dose form part Usages - Country Language * Spain Spanish operation id 6519944 Types - Reference * This is a dummy resource, to make the PMS examples links resolve for QA purposes - but these are not supported in the API currently confidentialityIndicator: Confidential operation Types - Reference * Bundle: type = transaction confidentialityIndicator: Public Characteristics - Type * true
StopCold 5 mg/120 mg comprimidos de liberación prolongada.
Effective Period: 2025-03-31.. Code: system: http://spor.ema.europa.eu/v1/lists/100000160406 code: 100000160480
Generated Narrative: RegulatedAuthorization identifier: http://ema.europa.eu/fhir/manufacturingAuthorizationNumber/12345 subject: Bundle: type = transaction type: Manufacturing Authorisation status: Valid validityPeriod: 2025-03-31 --> (ongoing) regulator: Finnish Medicines Agency (Identifier: http://spor.ema.europa.eu/v1/locations/LOC-100000015)